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los).Summary Rounded atelectasis of the lung (RA) is a lesion well described in the
medical literature, yet often very difficult to diagnose. In recent years, the
widespread use of high-resolution imaging modalities employed in the struggle
against cancer, coinciding with the peak of the asbestos epidemic, have boosted the
detection frequency of RA. However, its differential diagnosis still poses a challenge
to the pulmonary specialist and the radiologist, as little is known about its
pathogenesis. Furthermore, the multifactorial etiology of RA and its occasional
coexistence with lung cancer make the task of confidently ruling out malignancy
sometimes daunting. This article attempts to provide an update on RA’s etiology,
radiological evaluation, clinical management, and prognosis based on recent
advances in broadly available diagnostic modalities and minimally invasive
interventional procedures. An exemplary case of post-tuberculous RA is illustrated,
as RA often presents as an unusual finding of a fairly common disease.
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ahoo.grIntroduction
Although early reports of rounded atelectasis (RA)
date back to 1928, it remained poorly understood
for a long period of time.1 Hanke and Kretzschmar
refined its radiologic features, and proposed the
term ‘‘atelectatic pseudotumor of the lung’’ in
1980.2 The synonyms for RA that have been used
since it reflects the confusion on its pathogenesis:
Blesovsky’s syndrome; pleuroma; folded lung
atelectasis; shrinking pleuritis with atelectasis;
helical atelectasis; spherical and cylindrical atelec-
tasis.3–5 RA is the least common of all benigned.
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changes.6 It represents an unusual form of
peripheral lung collapse accompanying pleural
effusions. The mean age of RA patients in one
study was 65713 years; among them an 83% of
active or ex-smokers.7 This entity has also been
reported in non-smokers,8 and is a rare cause of
solitary pulmonary nodule (SPN) in immunocompe-
tent and immunocompromised patients.9 Besides
history and physical examination, plain chest
radiography used to be the only diagnostic tool
unraveling RA; the advent of computed tomography
(CT) contributed to a more accurate discrimination
of the lesion.10 Asbestos exposure is still the
leading etiologic factor for the development of
RA. Nevertheless, more infrequent causes are not
to be overlooked. Two main theories have
emerged addressing RA’s pathogenesis: the ‘‘folding
(pleural effusion)’’ and the ‘‘fibrosing (pleural
injury)’’ concepts.11,12 In this article, we
summarize pertinent clinical and radiological
aspects of RA, discuss its pathogenesis and
relationship to lung cancer, and attempt to
provide useful guidance to the physician managing
a case of RA.Table 1 Causes of RA.
 Exposure to mineral dusts
Asbestos (occupational and environmental)
Silica (occupational)
Mixed mineral dusts (occupational)
 Exudative pleural effusions
Parapneumonic effusion—Empyema
Tuberculous effusion
Hemothorax
Post-cardiac surgery
Chronic hemodialysis
 Without prominent pleural involvement
Legionella pneumophila pneumonia
Histoplasmosis
End-stage chronic renal failure
Sarcoidosis (?)
 Other
Pneumothorax (spontaneous, iatrogenic)
Childhood cancer
IdiopathicEtiology
RA was originally observed in patients treated with
collapsotherapy (i.e. induction of iatrogenic pneu-
mothorax for the treatment of cavitary pulmonary
tuberculosis). A striking predilection of RA for
patients with a history of pleurisy was noted shortly
thereafter. In the early 1980s, coinciding with the
discrimination of asbestos as a major public health
hazard, exposure to this mineral’s fibers was
implicated in the development of RA lesions.13
Asbestos-related RA was usually found coexisting
with other types of asbestos-induced pleuropul-
monary disease, and only occasionally solitary. Still
today, asbestos exposure is considered to be the
leading etiologic factor, accounting for 29–86% of
the cases of RA in various series.7,14 Not only
occupational, but also environmental asbestos
exposure has been associated with RA. One pioneer
report traced an unexpectedly high number of RA
patients without occupational asbestos exposure to
Metsovo, Greece, an area with documented envir-
onmental exposure to tremolite (‘‘Metsovo
lung’’).15 Inhalation of mineral dusts other than
asbestos, such as silica (silicosis-associated RA),
and mixed mineral dusts (mixed dust pneumoco-
niosis-associated RA), have also been reported to
cause RA.16,17However, it has been recently shown that pleural
effusions can lead to RA development in the
absence of asbestos or other mineral dust expo-
sure.18 RA more commonly develops during the
healing course of a pleural effusion, rather than
during the active disease process. Exudative/
inflammatory effusions that cause pleural thicken-
ing exhibit a greater propensity for RA generation
than transudative ones.11,19 Pleurisy is the second
leading cause of RA, accounting for approximately
14–64% of cases.14 RA has been observed with
virtually all types of pleural effusions. This fact
indicates its close association with the process of
pleural inflammation, and not the specific causa-
tive agent that triggers it. RA has been reported
with acute parapneumonic, chronic empyematous
and tuberculous effusions, post-traumatic he-
mothoraces, effusions after coronary artery sur-
gery, and effusions occuring in chronic hemodialysis
patients.14,20–22 In many cases pleural involvement
is clinically silent, and pulmonary parenchymal
disease dominates early clinical manifestations. In
these cases RA appears insidiously as a chronic
sequella of clinically silent pleurisy. In this setting,
RA has been reported with Legionella pneumophila
pneumonia, histoplasmosis, and end-stage chronic
renal disease.23–25 Finally, RA has been vaguely
associated with primary spontaneous pneumothor-
ax and secondary spontaneous pneumothorax due
to neurilemmomatosis. It has been reported in
children with cancer, and in a healthy young person
with no past medical history.8,26 A differential
diagnostic list of probable causes of RA is given in
Table 1.
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evaluation
RA is asymptomatic in the majority of cases. A
history of occupational asbestos exposure or pleur-
al disease may or may not be present. The physician
is usually struck by the disparity between extensive
radiological findings and scarce or absent clinical
signs. Occasionally patients may complain of chest
pain, dyspnea, or cough.14 Asbestos-related RA
tends to give symptoms more often than non-
asbestos-related RA. Even then, it is not clear if
symptoms are caused by the underlying disease
rather than by RA. Physical findings are minimal to
absent; the presence of a few scattered deep-
inspiratory crackles, accompanied by scarce fric-
tion rub heard over the affected area is the
exception in our experience. The prevalence of
smoking among RA patients has been reported to be
much higher than in the general population. This
fact may have significant implications in the
pathogenesis of RA lesions. RA is usually encoun-
tered in two clinical settings: either as an inciden-
tal finding in an otherwise healthy person with or
without a pleural history, or during long-term
follow-up of an asbestos exposed worker. The latter
situation poses a greater diagnostic challenge, as
RA has to be confidently discriminated from
malignancy in subjects that often have pulmonary
co-morbidity and therefore run a greater risk from
interventional procedures.
No laboratory test is sensitive or specific for RA.
One study found an elevated erythrocyte sedimen-
tation rate in patients suffering from extensive
pleural sequellae due to asbestos exposure, in
comparison to subjects suffering only from asbes-
tosis or pleural plaques.27 Solitary RA causes no
significant functional impairment, if it is not
accompanied by other pleural or parenchymal
sequellae, especially diffuse pleural thickening.28
Thus, functional impairment is common in patients
with asbestos-related RA that often have co-existing
diffuse parenchymal or pleural involvement, while
lung function studies are usually normal in non-
asbestos-related RA patients. Even when functional
impairment is present, it is non-specific; obstruc-
tive, restrictive, or mixed.28 Thus, lung function
testing serves only for follow-up purposes, and does
not provide clues on RA’s etiology.Radiological features
Imaging techniques are the sole laboratory tests
that possess satisfactory sensitivity and specificityfor RA. Older techniques, such as plain chest
radiography and plain tomography can simply out-
line the lesion, contributing little towards its
differential diagnosis from other round intrathor-
acic opacities. Even this is not always readily
accomplished, as an estimated 50% of RAs are
not detected by chest X-rays (CXR). However,
newer imaging modalities such as CT, high-resolu-
tion computed tomography (HRCT), ultrasonogra-
phy, magnetic resonance imaging (MRI), and
positron emission tomography (PET), can accu-
rately capture and delineate specific features of
RA. In recent years they have increased its
detection frequency, making it appear all the more
often in clinical practice. RA is usually solitary and
unilateral, but can occasionally be multiple and
bilateral. Up to three lesions have been reported in
the same patient.14,29 Non-asbestos-related RA is
commonly located in dependent (basal, posterior,
and paraspinal) lung regions. It also exhibits a
striking propensity for being located in the middle
lobe and the lingula. Expectedly, asbestos-related
RA is preferentially located in inhalational main-
stream targeted areas (lower lobes, lingula, middle
lobe). As these two patterns overlap to a large
extent, RA’s location does not suggest a specific
cause.Plain CXR findings
RA is most often discovered on CXR, where it
appears as a round, spindle-, or wedge-shaped
opacity with hazy, irregular borders, always mea-
suring less than 7 cm in diameter. It is located
peripherally, and is in contact with thickened
pleura. Its opacity emulates that of soft tissue,
and the angles formed by its borders and the pleura
are sharp. There is some degree of volume loss of
the ipsilateral lung field, and the ‘‘comet-tail’’ sign
is occasionally observed.30 This hallmark of RA is a
variation of the ‘‘cranial tilting’’ sign originally
described by Hanke. He defined it as ‘‘the abrupt
cephalad displacement of the linear opacities
(pulmonary vessels) immediately after exiting the
lesion’’.2 Frontal and lateral classic tomography is
no longer in routine use, and has been replaced by
CT. However, it used to hold additional diagnostic
value compared to CXR, since it better delineates
the ‘‘comet-tail’’ sign and the irregularly thickened
pleura.10 In some cases the ‘‘comet-tail’’ sign and
RA’s close proximity to the visceral pleura is not
obvious on CXR, and it appears as a SPN. These
primary CXR-features of RA are often accompanied
by secondary signs, such as diffuse pleural thicken-
ing, pleural effusion, pleural plaques, fibrothorax
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often helpful by suggesting the underlying cause.Table 2 Findings of RA on CT.
 Primary signs
Round, wedge- or lentiform-shaped mass
Soft-tissue density, with air bronchogram
Size: 3.5–7 cm
Subpleural location
Location
Often in middle lobe, lingula, lower
lobes
Seldom in right upper lobe, almost
never in left upper lobe
Converging bronchovascular markings, or
‘‘comet-tail’’ sign
Blurred hilar margins
Sharp angle between mass and pleural
surface
 Secondary signs
Adjacent pleural thickening
Volume loss of affected lobe
Fissure or main-stem bronchus displace-
ment
Dense periphery, more radiolucent center
Increased lucency of surrounding parench-
yma
Coexisting pleural plaques, diffuse pleural
thickening, pleural effusion
Coexisting parenchymal process (e.g. as-
bestosis)CT findings
With the advent of CT-scanning a new arsenal of
signs was developed that often facilitates non-
invasive diagnosis of RA. RA appears on CT-scans as
a rounded peripheral mass abutting thickened
pleura. Its diameter lies between 3.5 and 7 cm
and its density is close to that of soft tissue.
Enhancement after contrast agent injection is
observed, but is very variable. It exhibits specu-
lated margins that form sharp angles with the
pleural surface. Interlobar fissures or main stem
bronchi may be displaced as there is always some
degree of volume loss associated with RA.31
Calcifications and extraparietal pleural fat accu-
mulation may be found within the thickened
neighboring pleura or within the mass itself.31
RA’s hilar margins are spiculated by incoming
vessels.29 Before these vessels enter the lesion,
they are strangulated and angled, creating the
characteristic appearance of converging broncho-
vascular markings, alias the ‘‘comet-tail’’ sign,
which is the diagnostic hallmark of the lesion and
can be seen in virtually all cases.29,31 Ordinarily, RA
exhibits a centrally located air bronchogram. The
periphery of the lesion may appear denser than its
more radiolucent center.31 Mediastinal lymph nodes
are never enlarged in RA; the finding of hilar or
mediastinal lymph node enlargement is suggestive
of malignant disease. In silicosis-associated RA,
silicotic nodules can be seen inside RA lesions and
throughout the lung parenchyma.16 One study
concluded that the most useful CT-criteria for
diagnosing asbestos-related RA were: (a) contiguity
to areas of diffuse pleural thickening, (b) lentiform
or wedge-shaped outline, (c) volume-loss, and (d)
the ‘‘comet-tail’’ sign.32 The CT-findings of RA are
summarized in Table 2. Although HRCT is not
superior to conventional CT in imaging RA, they
have different capabilities of depicting coexisting
lesions. HRCT is much more valuable in uncovering
diffuse interstitial processes, whereas conventional
CT is highly sensitive and specific in delineating
pleural plaques.6 The choice between either
technique should rely on the clinical context of
RA’s presentation and on the findings on plain CXR
films.Coexisting silicotic nodules inside the
lesion
Calcification of the thickened pleura or of
the lesion itself
Extraparietal pleural fat accumulationUltrasound findings
Ultrasound scans have not improved diagnostic
accuracy for RA compared to CT-scans. However,they would be advantageous over CT if they could
reach equivalent resolutions for reasons of clinical
feasibility and radioprotection. Ultrasound findings
of RA include a pleural-based hyper-echogenic
area, adjacent pleural thickening with extrapleural
fat, and a highly echogenic line extending from the
pleura into the ‘‘mass’’, which is believed to
represent the scarred invaginated visceral pleura.33Magnetic resonance imaging findings
In recent years patients with RA have been studied
with MRI, and the MRI-signs of RA have been
recognized. The lesion produces a signal that is
higher than that of muscle and lower than that of
fat on T1-weighted images, while on T2-weighted
images the signal is similar to or lower than that of
fat. The atelectatic mass enhances homogeneously
after gadopentate dimeglumine administration.
The abutting thickened pleura produces no signal
and can be more clearly identified on T2-weighted
images. A characteristic ‘‘kidney-like’’ pattern, i.e.
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the lesion, is often visible. Converging bronchovas-
cular markings can sometimes be better observed
on saggital or oblique, rather than on transverse
images. MRI is also capable of more clearly
delineating the actual origin of the lesion: the
infolded visceral pleura.34 Though MRI is capable of
depicting the lesion in greater detail, it seems to
have little more to offer towards diagnosing RA
compared to CT.Positron emission tomography (PET) findings
RA has been shown to be metabolically inactive on
2-[18F]-fluoro-2-deoxy-D-glucose (FDG)-PET scans.
FDG-PET can therefore help in differential diagnos-
ing RA from malignant lesions when CT is equivo-
cal.35 This imaging modality is valuable in the
discrimination of malignant from non-malignant
SPNs (80% sensitivity, 94% specificity). Newer FDG-
PET techniques, like dual time-point FDG-PET hold
promise for even greater diagnostic accuracy (100%
sensitivity, 89% specificity).36 Limited spatial reso-
lution is overcome by CT-PET co-registration
images. A major limitation for widespread use of
FDG-PET as a first-line imaging modality for SPNs
and RA is its still limited availability and cost-
effectiveness.Figure 1 RA in a 30-year old male with a history of pleurop
Posteroanterior chest radiograph demonstrating an ill-defined
lobe, which is accompanied by converging bronchovascular m
ipsilateral hila and absence of visibility of the interlobar arteIllustrative case
A 30-year-old male non-smoking patient was sub-
jected to serial follow-up with annual CXRs in 1998.
He had just successfully completed an anti-tuber-
culous drug regimen for smear-positive reactivation
pulmonary tuberculosis accompanied by tubercu-
lous pleural effusion on the right (6-month/4-drug
regimen, consisting of isoniazide 300mg o.d. plus
rifampin 600mg o.d. for 6 months, with ethambutol
1200mg o.d. and pyrazinamide 1500mg o.d. for the
first 2.5 months). The pathogenic Mycobacterium
tuberculosis strain had tested completely drug-
sensitive. He had no occupational history of
asbestos exposure, nor did he live in an area with
documented environmental asbestos pollution. His
CXR was completely normal at the initiation of
follow-up. After 3 years of uneventful follow-up
and while remaining asymptomatic, the patient had
an abnormal chest radiograph (Fig. 1). An ill-
defined opacity was discovered in the right lower
lung field, accompanied by signs of right lower lobe
volume loss (converging bronchovascular markings,
mild caudad displacement of the ipsilateral hilum
and absence of visibility of the interlobar artery),
prompting immediate CT-evaluation. Typical CT-
scan findings suggested RA (Fig. 2). No further
diagnostic evaluation was deemed necessary, and
the patient was re-enrolled in yearly follow-upulmonary tuberculosis, at the 3 years’ follow-up session.
opacity in the posterior-medial aspect of the right lower
arkings. There is also a mild caudad displacement of the
ry (both are signs of right lower lobe volume loss).
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Figure 2 The same patient as in Fig. 1. (A) CT (soft tissue
window): a mass of soft tissue density is seen in the right
lower lobe paraspinally (white arrow) abutting a thick-
ened pleura (thin black arrows). The bold black arrow
points to a focus of calcification in the thickened pleura.
(B) HRCT: the ‘‘comet-tail’’ sign confirms the presumable
diagnosis (arrows).
G.T. Stathopoulos et al.620evaluation. The lesion has been stable and the
patient has not had symptoms since.Clinical course—management
RA is clinically benign. Complications, such as
bronchial obstruction, post-obstructive pneumonia,
and arterial thrombosis have been reported only
once in the same patient.37 However, when RA is
comprised in the spectrum of asbestos-induced lung
disease, it constitutes a rather ominous prognostic
sign. One study found asbestos-induced pleural
changes (such as RA) to be (a) overtly progressive,
(b) profound effectors of overall lung functionindependently of the presence of parenchymal
changes, and (c) hallmarks of ensuing parenchymal
involvement.38 The co-existence of pleural effu-
sions has also been found to be a dismal prognostic
marker for the development of CXR abnormalities
and lung function impairment.39 Thus, RA usually
follows a clinically silent and indolent course, but
the diseases processes that cause it may not do so.
The diagnosis of RA is based on radiologic criteria
with sufficient security. Most authorities agree that
CT is an almost perfect tool for the confident
diagnosis of RA, accurate enough to obviate
exploratory or resectional thoracotomy most of
the times. However, only one study has addressed
this matter systematically.40 The authors of this
study found adjacent pleural thickening and pleur-
al-based location to be the most sensitive markers
for RA (100% each), but lacking specificity (33% and
67%, respectively). They also found the sign of
converging bronchovascular markings (‘‘comet-tail
sign’’) to be most reliable (sensitivity 83%, speci-
ficity 92%) and concluded that although the
diagnostic accuracy of CT for RA was high it was
nevertheless imperfect. They stated that no single
CT-criterion alone, but rather a combination there-
of, is sufficient to securely exclude alternative
diagnoses. Additional imaging modalities, such as
MRI, FDG-PET or ultrasonography, can help as
adjuvant diagnostic tools in equivocal cases.
Fine needle aspiration or percutaneus CT-guided
biopsy are not indicated for the vast majority of
patients with typical RA. They probably have a role
in ambiguous cases, where radiologic criteria
cannot establish a firm diagnosis and rule out
malignancy. When implemented, it is important to
remember that only positive results are valuable;
the negative predictive value of these tests for
cancer is low due to limited sampling. In equivocal
cases of atypical, ill-defined masses in patients at
high risk for having cancer, the surgical procedure
of choice is video-assisted thoracoscopic surgery.
This procedure is associated with less morbidity and
mortality than open thoracotomy, and provides
satisfactory diagnostic accuracy.41 It should be
implemented before the final decision on open
lung biopsy. Video-assisted thoracoscopic surgery
nevertheless pre-requisites adequate lung function
because it is performed under general anesthesia
and selective main-stem bronchi pertubation.
Medical thoracoscopy, a recently emerged techni-
que that is even less invasive than video-assisted
thoracoscopic surgery, should be better suited for
patients who are borderline or inadequate in terms
of respiratory and/or cardiac reserve.42 These
minimally invasive procedures gain an even greater
role in the management of unoperable or border-
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cases, to which every possible exclusion criterion
for resectional surgery has to be applied. Explora-
tory surgery is frequently offered to RA patients as
the final diagnostic option; the leading cause for
this is the fear of malignancy.43 However, it is
important to remember that pathological confirma-
tion of the radiological diagnosis of RA is not
necessary in most instances.
The main differential diagnosis to RA is malig-
nancy originating in or metastasizing to the lung or
pleura, keeping in mind the rare case of coex-
istence of both. This is the reason for the
categorization of RA under the heading of ‘‘lung
pseudotumors’’. Other diseases that produce a
similar radiologic picture are round pneumonia,
round focuses of radiation pneumonitis, plasma cell
granuloma, Wegener’s granulomatosis, neurogenic
tumors, lung abscess, mycobacterial, fungal and
lymphoproliferative diseases, etc.
There is no specific treatment for RA. Surgical
intervention should be considered only if RA’s
impact on lung function is profound, or when
serious fear of coexisting malignancy is substan-
tiated.44,45Figure 3 Mechanism of rounded atelectasis formation.
(A) The ‘‘folding (pleural effusion) theory’’: increasing
pressure of accumulating pleural fluid (black arrow)
causes inward bulging of visceral pleura and atelectasis
of the underlying lung parenchyma (white arrows). (B)
The ‘‘fibrosing (pleural injury) theory’’: contraction of a
focus of visceral pleural fibrosis (vertical arrows) causes
shrinkage of underlying parenchyma (curved and hor-
izontal arrows). (C) Proposed ‘‘microbronchial distor-
tion’’: increasing pleural fluid pressure (black arrow),
and/or visceral pleural fibrotic plaque contraction (long
white arrow), cause displacement of underlying pulmon-
ary parenchyma (short white arrow), and distortion of
small bronchi (black arrowhead) with subsequent periph-
eral gas absorption.Discussion
RA can be found acutely at the time of discovery of
a pleural effusion, subacutely during decrease of a
pleural effusion or chronically long after a pleural
effusion or asbestos exposure.18,20 The main histo-
pathological lesion is a focus of local visceral
pleural fibrosis, underneath which lies a wrinkled
and folded pleura. The latter sometimes projects
deep invaginations into the underlying pulmonary
parenchyma. Not a discrete mass, but a com-
pressed lung region showing focuses of interstitial
fibrosis corresponds to the radiopacity.11 RA has
been found to be a purely visceral pleural lesion, in
contrast to pleural plaques, which are of parietal
pleural origin.
The mechanism of RA formation is still under
debate. Two main theories have emerged attempt-
ing to explain its development: the ‘‘folding
(pleural effusion)’’ and the ‘‘fibrosing (pleural
injury)’’ concepts.11,12 The ‘‘folding (pleural effu-
sion)’’ theory suggests that the initial event in the
pathogenesis of RA is lung parenchymal compres-
sion and subsequent invagination by loculized
accumulation of pleural fluid. The ‘‘fibrosing
(pleural injury)’’ theory suggests the initial event
for RA’s formation to be local visceral pleural
inflammation. This leads to repair, which in turnleads to fibrosis. The subsequent contraction of this
visceral pleural fibrotic focus leads to RA of the
underlying lung parenchyma (Figs. 3A and B). To
date both theories stand in a complementary
fashion. We propose microbronchial distortion as
an additional mechanism for RA formation (Fig.
3C). Strangulation of small airways with subsequent
peripheral gas absorption and focal atelectasis
could explain the preferential location of RA in
the middle lobe and the lingula and its epidemio-
logical association with smoking. In contrast to the
pleural thickening and parenchymal fibrosis con-
cepts, this mechanism could also explain the
observed late regression of chronically persistent
lesions.
The relationship of RA to malignancy comprises
two important issues. The first one is its close
resemblance to malignant lung and mesothelial
tumors, and the task of differential diagnosis
thereby set before the clinician and the radiologist.
The second issue is whether asbestos-related RA by
itself pre-disposes to malignancy or not. Only one
study has adressed the latter. The authors of this
study tried to correlate radiologic lesions with
mineralogic data in asbestos exposed individuals.46
They found statistically significant higher tissue
retention of asbestos bodies in patients with RA and
coexisting diffuse pleural thickening and/or inter-
stitial fibrosis, in comparison to patients with
isolated pleural plaques. They concluded that the
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lung cancer. On the contrary, the presence of
excessive risk for lung cancer in patients with RA
and pleural plaques only was more questionable, as
they were found to have asbestos body tissue
retentions either above or below those associated
with pleural plaques alone. Based on these data
one can conclude, that RA is not a pre-neoplastic
lesion per se, but that specific coexisting asbestos-
induced lesions in exposed individuals, in fact are.
Nevertheless, what asbestos-induced RA is con-
cerned; it is a sign of exposure to a known
carcinogen. Upon discovery of such a lesion,
patients should by all means be subjected to close
follow-up.Conclusion
Our knowledge about the entity called RA has
grown substantially in recent years. A great
proportion of this understanding has been aquired
in a non-systematic manner, probably due to the
small number of patients presenting with this
disorder. As the use of modern imaging modalities
results in increased detection frequency of RA, a
more uniform clinical management should be
implemented. RA is a part of the wide spectrum
of sequellae resulting from insults to the visceral
pleura by pathogenic processes. It is characterized
by great discrepancy between minimal clinical and
impressive radiologic findings. Awareness of this
uncommon entity is important if it is to be
diagnosed accurately.References
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